Abstract:ABSTRACT The ongoing transmission of influenza A viruses (IAV) for the past century continues to be a burden to humans. IAV binds terminal sialic acids (SA) of sugar molecules present within the upper respiratory tract (URT) in order to successfully infect hosts. The two most common SA structures that are important for IAV infection are those with α2,3- and α2,6-linkages. While mice were once considered to be an unsuitable system for studying IAV transmission due to their lack of α2,6-SA in the trachea, we have successfully demonstrated that IAV transmission in infant mice is remarkably efficient. This finding led us to re-evaluate the SA composition of the URT of mice using in situ immunofluorescence and examine its in vivo contribution to transmission for the first time. We demonstrate that mice express both α2,3- and α2,6-SA in the URT and that the difference in expression between infants and adults contributes to the variable transmission efficiencies observed. Furthermore, selectively blocking α2,3-SA or α2,6-SA within the URT of infant mice using lectins was necessary but insufficient at inhibiting transmission, and simultaneous blockade of both receptors was crucial in achieving the desired inhibitory effect. By employing a broadly acting neuraminidase to indiscriminately remove both SA moieties in vivo , we effectively suppressed viral shedding and halted the transmission of different strains of influenza viruses. These results emphasize the utility of the infant mouse model for studying IAV transmission and strongly indicate that broadly targeting host SA is an effective approach that inhibits IAV contagion. IMPORTANCE Influenza virus transmission studies have historically focused on viral mutations that alter hemagglutinin binding to sialic acid (SA) receptors in vitro . However, SA binding preference does not fully account for the complexities of influenza A virus transmission in humans. Our previous findings reveal that viruses that are known to bind α2,6-SA in vitro have different transmission kinetics in vivo , suggesting that diverse SA interactions may occur during their life cycle. In this study, we examine the role of host SA on viral replication, shedding, and transmission in vivo . We highlight the critical role of SA presence during virus shedding, such that attachment to SA during virion egress is equally important as detachment from SA during virion release. These insights support the potential of broadly acting neuraminidases as therapeutic agents capable of restraining viral transmission in vivo . Our study unveils intricate virus-host interactions during shedding, highlighting the necessity to develop innovative strategies to effectively target transmission.

[Recombinant influenza A virus NS2 protein inhibits the production of interferon in lung tissues of infected mice]

Influenza Virus NS1 Interacts with 14-3-3ε to Antagonize the Production of RIG-I-mediated Type I Interferons.

Inhibition of Influenza Virus Production in Virus-Infected Mice by RNA Interference.

Effective Inhibition of Mrna Accumulation and Protein Expression of H5N1 Avian Influenza Virus NS1 Gene in Vitro by Small Interfering RNAs

Inhibitory Effect of Recombinant Human Interferon Α-2B on Influenza Virus

Inhibition of the Antigen-Presenting Ability of Dendritic Cells by Non-Structural Protein 2 of Influenza A Virus

Comparison of Transcriptional Repression on IFN-β with Two Different Kinds of Pathogenic Influenza Virus NS1 Proteins

The Interferon-Induced Protein with Tetratricopeptide Repeats Repress Influenza Virus Infection by Inhibiting Viral RNA Synthesis

Influenza A virus NS1 protein represses antiviral immune response by hijacking NF-κB to mediate transcription of type III IFN

Effective Small Interfering RNAs Targeting Matrix and Nucleocapsid Protein Gene Inhibit Influenza A Virus Replication in Cells and Mice

Influenza virus non-structural protein 1 inhibits the production of interferon β of alveolar epithelial cells upon the infection of influenza A H1N1

Effect of Recombinant Human Interferon Α1b on Lung Tissue Pathology and Janus Kinase(jak)/signal Transducer and Activator of Transcription (STAT) Signal Pathway in Mice Infected by Respiratory Syncytial Virus

The interferon-induced protein, IFIT2, requires RNA-binding activity and neuronal expression to protect mice from intranasal vesicular stomatitis virus infection

Lnc-RPS6P3 Inhibits Influenza A Virus Replication and Attenuates the Inhibitory Effect of NS1 on Innate Immune Response

Construction of an inhalable recombinant M2e-FP-expressing Bacillus subtilis spores-based vaccine and evaluation of its protection efficacy against influenza in a mouse model

Impact of Influenza A Virus Shutoff Proteins on Host Immune Responses

Study on the Pharmacodynamics of Interferon-α2a Buccal Adhesive Tablet against Influenza Virus Infection

In vivo inhibition of influenza A virus replication by RNA interference targeting the PB2 subunit via intratracheal delivery

[Study Progress of NS1 Protein of Influenza A Virus].

Inhibiting influenza virus transmission using a broadly acting neuraminidase that targets host sialic acids in the upper respiratory tract

Construction of Influenza Virus Sirna Expression Vectors and Their Inhibitory Effects on Multiplication of Influenza Virus.